• Company
• Boryung speeds up Lenvima patent challenge
• by Heo sung-kyu Apr 4, 2024 06:00am

• Company
• Enhertu lands in general hospitals in KOR after reimb
• by Eo, Yun-Ho Apr 4, 2024 06:00am

• Policy
• Eye drops late to submit test results pass reivew
• by Lee, Hye-Kyung Apr 4, 2024 05:59am

• Policy
• K-CAB is in talks to extend refund-type PVA
• by Lee, Tak-Sun Apr 4, 2024 05:59am

• Company
• AbTis-Progen signs MOU to develop bispecific antibody ADC
• by Son, Hyung-Min Apr 3, 2024 05:51am

• Company
• Hanmi files phase 1 FDA IND for their next-gen obesity drug
• by Son, Hyung-Min Apr 3, 2024 05:50am

• Company
• Pharmas face sales challenges and rebate monitoring
• by Son, Hyung-Min Apr 3, 2024 05:50am

• Company
• Pfizer expands co-marketing partnership deals
• by Son, Hyung-Min Apr 3, 2024 05:50am

• Company
• Kukje Pharm and Celltrion will comarket Eylea biosimilar
• by Nho, Byung Chul Apr 3, 2024 05:50am

• Policy
• Novartis’ 'Ilaris' will be reconsidered for the DREC review
• by Lee, Tak-Sun Apr 3, 2024 05:50am